Associate Director, Quality Assurance

The Early Development Quality Lead is responsible for the strategic quality oversight of internal and external (outsourced) activities in support of nonclinical studies (GLP and non-GLP), IND enabling work, as well as the utilization of Biomarkers within development programs (preclinical and clinical).

This role will partner with Alnylam colleagues within Early Development, Bioanalytical, Nonclinical Writing, Research, and Clinical Research to provide quality support and oversight and ensure the identification, mitigation, and escalation of emerging quality risks and concerns.

This position will be located within the US and can be hybrid, onsite, or remote.

Key Responsibilities

• Sets the strategic quality oversight direction for internal and outsourced laboratory activities supporting nonclinical studies (GLP and non-GLP), including toxicology, bioanalyitical and biomarker data that supports IND submissions.
• Establish and maintain quality oversight of external laboratories including Test Facilities, Test Sites, and Clinical Laborities by implementing governance framework and ongoing performance monitoring.
• Collaborate with nonclinical and clinical teams (in partnership with GCP Program Leads) to integrate quality considerations into the selection, contracting, and management of external labs.
• Ensure internally developed and outsourced biomarker development / analytical work complies with internal quality system requirements and external regulatory standards including GCP, GLP, ICH, and OECD.
• Refine and continuously implement robust, risk-based vendor oversight and audit program globally for nonclinical work. Lead the risk assessment and audit strategy for external laboraties and ensuer planned audits are executed in alignment with the GCP/GLP yearly audit program.
• Support the management of nonclinical and clinical lab focused quality issues arising from outsourced activities, including quality events, significant quality issues, and CAPA oversight.
• Serves as the Quality escalation point for CRO/vendor quality issues and leads quality governance activities to ensure appropriate identification, issue escalation and the mitigation of emerging compliance risks.
• Provides quality strategic direction for the functional evaluation of CRO or key vendor processes or process improvement opportunities.
• Drive the strategic identification and implementation of process improvement opportunities within Alnylam's QMS, in support of early development and research.
• Partners with Legal/Procurement for appropriate oversight language in contractual agreements and ensure compliance

Qualifications

• Educated preferably in life sciences (technology, biological science, pharmacy or other health related discipline preferred) or equivalent qualification or work experience. Master's degree in a science, technology or industry related discipline, preferred.
• Minimum of 10 years of relevant experience, inclusive of bioanalytical and toxicology subject matter, as it relates to GLPs, GCPs and GCLPs.
• Direct experience in the field of assay development and validation and familiar with biomarker-based assays (e.g., PCR, ELISA, FISH) is preferred.
• Prior experience in risk-based thinking, quality assurance, auditing, managing quality issues/escalations, or other relevant QMS elements.
• Prior expertise in global GLP, GCP, GCLP regulations and guidances across regulatory bodies such as FDA, PMDA, European Union, MHRA, etc.

#LI-EL1

U.S. Pay Range

$161,000.00 - $217,800.00

The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam's robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers

AboutAlnylam

We are the leader in RNAi therapeutics- a revolutionaryapproach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possibleand are just at the beginning of what's possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, wherean authentic, inclusive culture and breakthrough thinkingfuel one another.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.